SNV · As filed with the SEC
Synovus Financial cash flow statement, by quarter
The statement as Synovus Financial presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
CONSOLIDATED STATEMENTS OF CASH FLOWS · USD thousands
| USD thousands | Q3 2025† 3 months ended Sep 30, 2025 | Q2 2025† 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| Operating Activities | ||||
| Net income | 196,505† | 217,119† | 194,872 | 189,377† |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||
| Provision for (reversal of) credit losses | 21,689† | 3,245† | 10,921 | 32,867† |
| Depreciation, amortization, and accretion, net | 16,722† | 13,530† | 11,543 | 12,860† |
| Deferred income tax expense (benefit) | (1,195)† | 2,508† | 6,787 | 4,355† |
| Originations of loans held for sale | (2,204,773)† | (2,011,454)† | (1,544,628) | (1,639,433)† |
| Proceeds from sales and payments on loans held for sale | 2,213,434† | 1,983,084† | 1,515,593 | 1,672,212† |
| Gain on sales of loans held for sale, net | (3,435)† | (3,278)† | (2,523) | (1,684)† |
| (Increase) decrease in other assets | (89,181)† | 324,290† | (96,746) | (113,459)† |
| Increase (decrease) in other liabilities | 50,369† | (354,926)† | (50,058) | 96,364† |
| Investment securities (gains) losses, net | (1,742)† | — | — | 0† |
| Share-based compensation expense | 8,042† | 9,111† | 6,496 | 7,986† |
| Loss on sales of loans | — | — | — | 0† |
| Net gain on sales of other real estate and other assets held for sale | (711)† | 0† | (355) | (626)† |
| Other | — | — | — | 0† |
| Net cash provided by (used in) operating activities | 205,724† | 183,229† | 51,902 | 260,819† |
| Investing Activities | ||||
| Net cash received (paid) for business combination and divestiture | — | — | — | 0† |
| Proceeds from maturities and principal collections of investment securities held to maturity | 69,863† | 60,939† | 49,571 | 57,474† |
| Proceeds from maturities and principal collections of investment securities available for sale | 153,859† | 145,418† | 125,397 | 136,752† |
| Proceeds from sales of investment securities available for sale | 173,996† | — | — | 0† |
| Purchases of investment securities available for sale | (42,532)† | (47,148)† | (277,156) | (385,667)† |
| Net proceeds from sales of loans | 5,094† | 9,248† | 37 | 12,328† |
| Purchases of loans | — | — | — | 0† |
| Net (increase) decrease in loans | (257,977)† | (912,850)† | (56,802) | 475,388† |
| Net (purchases) redemptions of Federal Home Loan Bank stock | 26,125† | (85,518)† | (16,878) | 36,812† |
| Net (purchases) redemptions of Federal Reserve Bank stock | (230)† | 202† | (287) | (314)† |
| Net proceeds from settlement (purchases) of bank-owned life insurance policies | 4,233† | — | — | 4,172† |
| Net increase in premises, equipment and software | (7,070)† | (6,532)† | (8,158) | (11,768)† |
| Proceeds from sales of other real estate and other assets held for sale | 1,840† | 0† | 2,534 | 1,585† |
| Net cash provided by (used in) investing activities | 127,201† | (828,708)† | (181,742) | 326,762† |
| Financing Activities | ||||
| Net increase (decrease) in deposits | 77,666† | (923,192)† | (258,749) | 905,813† |
| Net increase (decrease) in federal funds purchased and securities sold under repurchase agreements | — | — | (48,726) | 37,673† |
| Net increase (decrease) in other short-term borrowings | — | — | 0 | 0† |
| Net increase (decrease) in federal funds purchased, securities sold under repurchase agreements, and other short-term borrowings | (22,860)† | — | — | — |
| Repayments and redemption of long-term debt | (900,000)† | — | — | (775,000)† |
| Proceeds from long-term debt, net | 0† | 1,800,000† | 350,000 | 496,791† |
| Dividends paid to common shareholders | (54,124)† | (54,736)† | (53,657) | (53,958)† |
| Dividends paid to preferred shareholders | (11,404)† | (11,395)† | (11,323) | (11,577)† |
| Repurchases of common stock | 17† | (21,437)† | (120,849) | (49,697)† |
| Issuances, net of taxes paid, under equity compensation plans | (329)† | (3)† | (14,610) | 2,749† |
| Net cash provided by (used in) financing activities | (911,034)† | 791,562† | (157,914) | 552,794† |
| Increase (decrease) in cash and cash equivalents including restricted cash | (578,109)† | 146,083† | (287,754) | 1,140,375† |
| Cash, cash equivalents, and restricted cash, at beginning of period | 2,852,316 | 2,706,233 | 2,993,987 | 1,853,612 |
| Cash, cash equivalents, and restricted cash at end of period | 2,274,207 | 2,852,316 | 2,706,233 | 2,993,987 |
| Supplemental Disclosures: | ||||
| Income taxes paid | 36,179† | 31,444† | 30,303 | 13,751† |
| Interest paid | 330,751† | 319,109† | 327,399 | 336,445† |
| Non-cash Activities | ||||
| Loans foreclosed and transferred to other real estate | 21,357† | 635† | 403 | 0† |
| Investment securities transferred from available for sale to held to maturity | 0† | — | — | 0† |
| Settlement of acquired debt | — | — | — | 0† |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.